Condition
GEJ Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 GEJ Adenocarcinoma clinical trials that are recruiting, at sites in 3 countries (most in United States (2), China (1), Australia (1)). By phase: Phase 1 (2), Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest GEJ Adenocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| XYA02 in advanced solid tumors | Phase 1/2 | Sydney, New South Wales and 4 other locations | Recruiting | Jun 26, 2026 |
| AVA6103 for advanced or metastatic FAP-positive solid tumors | Phase 1 | Scottsdale, Arizona and 6 other locations | Recruiting | Mar 6, 2026 |
| Fruquintinib with trastuzumab and XELOX for first-line treatment of HER2‑positive advanced stomach or GEJ cancer | Phase 1/2 | Zhengzhou, Henan | Recruiting | Jan 12, 2026 |
| NRM-823 for advanced or metastatic refractory solid tumors | Phase 1 | Denver, Colorado and 17 other locations | Recruiting | Sep 19, 2025 |
All recruiting trials (4)
-
XYA02 in advanced solid tumors
This trial tests XYA02 in adults with MUC1-expressing advanced or relapsed solid tumors to see if it is safe, tolerable, and can shrink tumors.
-
AVA6103 for advanced or metastatic FAP-positive solid tumors
This study will test whether the experimental IV drug AVA6103 is safe and can help adults with advanced or metastatic FAP-positive cancers such as pancreatic, gastric/GEJ, cervical, or vulvar adenocarcinomas.
-
Fruquintinib with trastuzumab and XELOX for first-line treatment of HER2‑positive advanced stomach or GEJ cancer
This trial will try fruquintinib together with trastuzumab and XELOX to see if it helps people with HER2‑positive advanced stomach or gastroesophageal junction cancer as their first treatment.
-
NRM-823 for advanced or metastatic refractory solid tumors
This trial tests whether NRM-823 is safe and can help people with advanced or metastatic head and neck, esophageal, gastric, or related cancers.
Related topics
Quick answers
How many GEJ Adenocarcinoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), China (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.